stella
beta
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO — Stella
Home
/
Ischemic Heart Disease
/
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
View on ClinicalTrials.gov
Recruiting
Back to Ischemic Heart Disease trials
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(27 sites)
Denmark
Aarhus University Hospital, Aarhus N
Rigshospitalet, Copenhagen
Gentofte Hospital, Hellerup
Odense University Hospital, Odense
Zealand University Hospital, Roskilde
Estonia
North-Estonia Medical Centre, Tallinn
Finland
Helsinki University Central Hospital, Helsinki
Kuopio University Hospital, Kuopio
Heart Hospital Tampere, Tampere
Turku University Hospital, Turku
France
Clinique Louis Pasteur, Essey-lès-Nancy
Cardiovascular Institute, Groupe Hospitalier Mutualiste, Grenoble
Spain
Hospital Germans Trias I Pujol, Badalona, Barcelona
Hospital Galdakao, Galdakao, Bizkaia
Hospital Vall de Hebron, Barcelona
Hospital Clinic, Barcelona
Hospital de Bellvitge, Barcelona
Hospital Universitario Clinico San Carlos, Madrid
Hospital la Paz, Madrid
Hospital Universitari de Tarragona Joan XXIII, Tarragona
Sweden
Sahlgrenska University Hospital, Gothenburg
Skaane University Hospital (Lund), Lund
Stockholm South Central Hospital (Södersjukhuset), Stockholm
United Kingdom
Belfast Health and Social Care Trust, Department of Cardiology, Belfast
University Hospital Bristol, Bristol
Barts Health NHS, London
St George's University Hospital, London